News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Aleix Prat: HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants
Photo taken from Aleix Prat/X
May 19, 2024, 09:02

Aleix Prat: HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants

Aleix Prat, CoFounder of Reveal Genomics, shared a post on X:

“HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.

Led by Francesco Schettini, Matteo Lambertini.”

Read further.
Source: Aleix Prat/X

Aleix Prat cancer Francesco Schettini HER2‐low breast cancer Matteo Lambertini OncoDaily Oncology
Special Coverage
Blog
Feb 21, 2025, 10:55
Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology
Blog
Feb 21, 2025, 10:45
Saurabh Zanwar: Clonal plasma cell proportion in the S-phase in multiple myeloma
Blog
Feb 21, 2025, 10:37
Cihangir Akyol: A comprehensive review on colorectal ESD outcomes by Lumir Kunovsky
Celebrities
Feb 21, 2025, 10:28
In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer
Science
Feb 21, 2025, 10:07
Elai Davicioni: Predicting Dose-Response to Prostate Cancer Radiotherapy
Blog
Feb 21, 2025, 10:00
Alexios Matikas: Adjuvant endocrine treatment strategies for non-metastatic breast cancer
Blog
Feb 21, 2025, 09:58
Miriam Mutebi: February - a whirlwind of learning, collaboration, and action
Blog
Feb 21, 2025, 09:54
The publication of the European Commission Work Programme for 2025 - ESMO
Blog
Feb 21, 2025, 09:45
Michelle Kirschner: New programming at the Cancer Survivorship Provider Network
Science
Feb 21, 2025, 09:39
M. Bilal Abid: Excited to present at the UT San Antonio MD Anderson Cancer Center
Blog
Feb 21, 2025, 09:35
UICC is seeking an Executive Director to lead the ATOM Coalition in Geneva
Blog
Feb 21, 2025, 09:18
Belén Garijo: A very important evolution of Merck Group's Executive Board